Promotional Tracking - Blog (Page 2)

COVID-19 Impact: The Future of In-person and Omni-channel Promotion

The COVID-19 pandemic led to significant changes in the way pharma engaged with healthcare practitioners (HCPs). To better understand these trends, ZoomRx analyzed over 20,000 sales rep interactions during the COVID-19 pandemic,

Covid-19

Q2 Earnings Calls Provide Insight on the Future of In-Person Promotional Activity

A return to pre-pandemic levels of in-person promotional activity looks increasingly uncertain in H2 2020. Given this uncertainty, pharmaceutical manufacturers, from diversified, multinational firms to more focused, growth-stage companies are navigating the complexities

Covid-19

Q1 Earnings Calls Provide Insight into the Future of In-Person Promotional Activity

Pharmaceutical manufacturers, from diversified, multinational firms to focused, growth-stage companies are adapting to the reality of COVID-19. Recent Q1 investor calls provide insight into both the impact of the pandemic thus far on

Promotional Tracking

How 5 Lessons from Rare disease Market Research Apply to Patient Segments in Common Diseases

The continued growth of personalized medicine and other treatment trends presents new challenges for market researchers. Within patient populations that were once considered relatively homogenous, new, smaller patient subgroups are being identified as

Promotional Tracking

Evaluating Print vs. Digital Aids in Oncology

Equipping reps with digital visual aids is a time and cost-intensive exercise. Consequently, sales leadership teams find themselves grappling with the questions: The conventional logic is that digital aids enable sales reps to

Promotional Tracking

We’ve tracked oncology promotional efforts for 120+ brands across 60,000 interactions over the last 5 years.

This post was updated with refreshed data as of 1/30. The high-level findings as reported by Fierce Pharma are available here. Below are 4 keys to driving high-impact details... Oncology sales strategies